Other

China/US trade deal strengthens IP protection in China for pharmaceutical companies

David Shen

On 16 January 2020, China and the United States signed the Economic and Trade Agreement between the Government of the People’s Republic of China and the Government of the United States of America (the Phase One Trade Agreement). The Phase One Trade Agreement includes a chapter on intellectual property aimed at resolving a wide range Read More

New EU Directive on Whistleblower Protection will also apply to Life Sciences sector

Inge Vanderreken

On 7 October 2019, the Council of Ministers adopted the Directive on Whistleblower protection at the Justice and Home Affairs Council in Luxembourg. The Directive will introduce new EU-wide rules to protect whistleblowers who report breaches of EU law. “EU law breaches” include, amongst others, those relating to EU laws on product safety and compliance, Read More

China: NMPA Seeks Comments on Draft Regulations of Drug Registration, Manufacturing and Distribution

David Shen

On 30 September 2019, the Chinese National Medical Products Administration (the NMPA) published three sets of draft regulations seeking public comment. They are the Draft Drug Registration Regulations, the Draft Manufacturing Regulations and the Draft Drug Distribution Regulations. The Ministry of Justice further updated these Draft Regulations on 15 October 2019 and is seeking public Read More

Amendment to Social Security Financing Bill seeks to provide clear legal basis for French medical cannabis pilot programme

Eveline Van Keymeulen

On 10 October 2019, French Deputy Olivier Veran introduced an amendment to the 2020 Social Security Financing Bill, in order to provide a clear legal basis for the medical cannabis pilot programme that was endorsed by the French National Agency for Medicines and Health Products Safety (ANSM) in July. The amendment is strictly speaking not Read More

Netherlands: Hospitals request three-year suspension of Dutch Competition Act

Hannah Smit

The Dutch Association of Hospitals (NVZ) has published a press release announcing that it has appealed for a three-year temporary suspension of the Dutch Competition Act in the healthcare sector, as various healthcare institutions have entered into arrangements to save on costs that may be in violation of the Act. For example, the institutions have Read More